Lipocine
LPCN
#10187
Rank
A$27.5 M
Marketcap
A$4.95
Share price
0.61%
Change (1 day)
-38.43%
Change (1 year)

Market capitalization of Lipocine (LPCN)

Market cap: A$27.5 Million

As of December 2025 Lipocine has a market cap of A$27.5 Million. This makes Lipocine the world's 10187th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Lipocine from 2013 to 2025

End of year Market Cap

Year Marketcap Change
2025A$27.5 M-32.79%
2024A$40.92 M88%
2023A$21.76 M-57.93%
2022A$51.74 M-57.13%
2021A$0.12 B3.89%
2020A$0.11 B461.31%
2019A$20.69 M-48.39%
2018A$40.1 M-57.06%
2017A$93.39 M0.18%
2016A$93.22 M-71.21%
2015A$0.32 B293.79%
2014A$82.23 M-29.82%
2013A$0.11 B

End of Day market cap according to different sources

On Dec 8th, 2025 the market cap of Lipocine was reported to be:

A$27.33 Million
by Nasdaq info icon info icon
A$27.33 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Seagen
SGEN
A$64.98 B 236,159.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
A$15.01 B 54,491.25%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Agile Therapeutics
AGRX
A$15.7 M-42.92%๐Ÿ‡บ๐Ÿ‡ธ USA